INDIA IPO
  • Home
  • About
    • About us
    • Our CSR
  • Services

    IPO

    • Initial Public Offering (IPO)
    • SME IPO Consultation
    • Mainline IPO Consultation
    • Follow-On Public Offer (FPO)
    • Pre-IPO Funding Consultants

    Capital Raising

    • Social Stock Exchange
    • Private Placement
    • Project Funding
    • REIT
    • SM REIT
    • Rights Issue Advisory
    • InvIT Rights Issue
    • InvIT Public Issue
    • InvIT Private Issue
    • Debt Syndication
    • Securitised Debt Instruments
    • Public Municipal Debt
    • Private Municipal Debt

    Finance Advisory

    • Business Valuation
    • Corporate Finance
    • Financial Modelling
    • Project Finance
  • Investors
  • Merchant Bankers

    SME

    • List of SME Merchant Bankers

    MAINBOARD

    • List of Mainboard Merchant Bankers
  • Resources

    Reports

    • Daily Reporter
    • IPO Calendar
    • Mainline IPO Report
    • SME IPO Report
    • SME IPOs by Sector
    • Mainboard IPOs by Sector

    IPO Knowledge

    • IPO World Magazine
    • IPO Process
    • Pre-IPO Process Guidance
    • IPO Blogs
    • Sector Wise IPO List In India
    • List of IPO Registrar

    Notifications / Circulars

    • BSE SME Eligibility Criteria
    • SEBI ICDR Amendment Regulations March 2025
    • SEBI SME IPO ICDR Amendments report Mar–Nov 2025
    • NSE Emerge Eligibility Criteria
    • ICDR
  • News/Updates
    • Markets & Money Update
    • IPO & Market Snaps
  • Contact Us
  • Check IPO Feasibility
Check IPO Feasibility
INDIA IPO
INDIA IPO

Contact Info:

  • +91-96506-37280
  • +011-47008280
  • info@indiaipo.in
  • 808, 8thFloor D-Mall, Netaji Subhash Place, Pitampura, Delhi-110034.
shape
  1. Home
  2. News
  3. Greaves Cotton Approves Grant of Up to 3,39,229 Employee Stock Options Under ESOP 2024
ipo services in India
India IPO
  • 05 May 2026
  • X
 Greaves Cotton Approves Grant of Up to 3,39,229 Employee Stock Options Under ESOP 2024

Greaves Cotton's Nomination and Remuneration Committee, at its meeting on May 5, 2026, approved the grant of up to 3,39,229 stock options under ESOP 2024. The options carry an exercise price of Rs. 2/- per option and may be exercised within 8 years from the vesting date. The grant is compliant with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The disclosure was made to both BSE Limited and the National Stock Exchange of India Limited.

Greaves Cotton Approves Grant of Up to 3,39,229 Employee Stock Options Under ESOP 2024

The Nomination and Remuneration Committee of the Board of Directors of Greaves Cotton approved the grant of up to 3,39,229 (Three Lakh Thirty-Nine Thousand Two Hundred and Twenty-Nine) stock options at its meeting held on May 5, 2026. The grant has been made under the Greaves Cotton Employee Stock Option Plan 2024 (ESOP 2024), in compliance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 (SEBI SBEB & SE Regulations), as amended from time to time.

Key Details of the Stock Option Grant

The following table outlines the key parameters of the stock options granted under ESOP 2024:

Parameter: Details Number of Options Granted: Up to 3,39,229 (Three Lakh Thirty-Nine Thousand Two Hundred and Twenty-Nine) Scheme Compliance: Yes — in terms of SEBI SBEB & SE Regulations Total Shares Covered: 3,39,229 Exercise Price: Rs. 2/- per option Exercise Window: Up to 8 years from the vesting date

Regulatory Compliance

The grant has been made in accordance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The company confirmed that the scheme is fully compliant with the applicable regulatory framework. The intimation was formally communicated to BSE Limited and the National Stock Exchange of India Limited as part of the company's listing obligations.

Greaves Cotton's Group General Counsel and Company Secretary, Atindra Basu (Membership No.: F13799), signed the disclosure on behalf of the company.

Greaves Cotton has allotted 45,173 fully paid-up equity shares of face value Rs. 2/- each under its Employee Stock Option Plan 2020, as disclosed pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The allotment was approved by the Nomination and Remuneration Committee of the Board of Directors at its meeting held on 05 May 2026.

ESOP Allotment Details

The shares were allotted following the exercise of stock options by eligible employees under the Greaves Cotton – Employee Stock Option Plan 2020. The newly allotted equity shares shall rank pari-passu with the existing equity shares of the company in all respects, including dividend and voting rights.

The key details of the allotment are summarised below:

Parameter: Details Allotment Date: 05 May 2026 Number of Shares Allotted: 45,173 Face Value per Share: Rs. 2/- Plan: Greaves Cotton – Employee Stock Option Plan 2020 Regulatory Compliance: Regulation 30, SEBI (LODR) Regulations, 2015

Impact on Share Capital

Following this allotment, the issued, subscribed, and paid-up share capital of Greaves Cotton has been revised upward. The updated capital structure is as follows:

Capital Parameter: Post-Allotment Figure Total Paid-Up Share Capital: Rs. 46,59,02,868/- Total Number of Equity Shares: 23,29,51,434 Face Value per Share: Rs. 2/-

The disclosure was signed by Atindra Basu, Group General Counsel and Company Secretary of Greaves Cotton, with Membership No. F13799, confirming the regulatory filing on behalf of the company.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

Source: scanx.trade

Recent News

Mafatlal Industries Allots 15,000 Equity Shares Under Employee Stock Option Scheme 2017 (3rd Grant)
Mafatlal Industries Allots 15,000 Equity Shares Under Employ...

Source: scanx.trade

05 May 2026
IDFC FIRST Bank Allots 55,02,631 Equity Shares to Employees Under Stock Option Scheme
IDFC FIRST Bank Allots 55,02,631 Equity Shares to Employees...

Source: scanx.trade

05 May 2026
Controversy Erupts Over Telangana's Shift to DBT for Fee Reimbursement
Controversy Erupts Over Telangana's Shift to DBT for Fee Rei...

Source: Deccan Chronicle

05 May 2026
DCM Shriram Board Meeting Scheduled on May 12-13, 2026 to Consider Q4FY26 Audited Results and Final Dividend
DCM Shriram Board Meeting Scheduled on May 12-13, 2026 to Co...

Source: scanx.trade

05 May 2026
SPML Infra Shareholders Approve Related Party Transactions and Director Remuneration via Postal Ballot
SPML Infra Shareholders Approve Related Party Transactions a...

Source: scanx.trade

05 May 2026
OnEMI Technology IPO subscribed 9.50 times on final day
OnEMI Technology IPO subscribed 9.50 times on final day

Source: Moneycontrol

05 May 2026
Bagmane Prime Office REIT IPO subscribed 71% on day 1
Bagmane Prime Office REIT IPO subscribed 71% on day 1

Source: Moneycontrol

05 May 2026
F MEC International EGM: Scrutinizer's Report Confirms Unanimous Approval of Share Split, Bonus Issue and Director Redesignation
F MEC International EGM: Scrutinizer's Report Confirms Unani...

Source: scanx.trade

05 May 2026
BAG Films & Media Receives Listing Approval from BSE and NSE for 98,00,000 Preferential Equity Shares
BAG Films & Media Receives Listing Approval from BSE and NSE...

Source: scanx.trade

05 May 2026
Sandu Pharmaceuticals Reports FY26 Net Profit of Rs. 176.61 Lakhs; Recommends Rs. 1 Per Share Dividend
Sandu Pharmaceuticals Reports FY26 Net Profit of Rs. 176.61...

Source: scanx.trade

05 May 2026
pre ipo advisory services in India
  • GST No: 07AAHCB7068H2ZF

India IPO is a leading Indian business services platform that helps firms and companies to launch their initial public offerings (IPOs) in order to raise essential capital for growth and expansion while adding value & fueling the nation’s immense potential and future opportunities.

Follow us:

Facebook Twitter LinkedIn Instagram YouTube

Quick Links

  • Home
  • Blogs
  • Consultant
  • Youtube Videos
  • News
  • Contact Us
  • Career

Contact Information:

  • Corporate Office: 808, 8th Floor, D-Mall, Netaji Subhash Place, Pitampura, Delhi-110034
  • Regional Office: Office No. 601, Shagun Insignia, Ulwe, Sector-19, Navi Mumbai- 410206
  • Email: info@indiaipo.in
  • Mobile: +91-74283-37280, +91-96509-82781
  • Disclaimer  |
  • Privacy & Policy  |
  • Terms & Conditions  

Copyright © All rights reserved by - Bmarkt Tecamat Private Limited